AEs (≥15%) for patients in part 1 (N = 12)
Preferred term . | All grades, n (%) . | Grade ≥3, n (%) . |
---|---|---|
Cough | 5 (41.7) | 0 |
Neutropenia | 5 (41.7) | 2 (16.7) |
Upper respiratory tract infection | 4 (33.3) | 0 |
Contusion | 3 (25) | 0 |
Dyspnea | 3 (25) | 1 (8.3) |
Fatigue | 3 (25) | 0 |
Peripheral swelling | 3 (25) | 1 (8.3) |
Petechiae | 3 (25) | 0 |
Abdominal distension | 2 (16.7) | 0 |
Arthralgia | 2 (16.7) | 0 |
Basal cell carcinoma | 2 (16.7) | 0 |
Chronic obstructive pulmonary disease | 2 (16.7) | 1 (8.3) |
Electrocardiogram QT prolonged | 2 (16.7) | 1 (8.3) |
Epistaxis | 2 (16.7) | 0 |
Gastroesophageal reflux disease | 2 (16.7) | 0 |
Nausea | 2 (16.7) | 0 |
Nephrolithiasis | 2 (16.7) | 1 (8.3) |
Edema peripheral | 2 (16.7) | 0 |
Oral herpes | 2 (16.7) | 0 |
Pruritus | 2 (16.7) | 0 |
Rhinitis allergic | 2 (16.7) | 0 |
Sinusitis | 2 (16.7) | 0 |
Squamous cell carcinoma of skin | 2 (16.7) | 0 |
Thrombocytopenia | 2 (16.7) | 1 (8.3) |
Urinary tract infection | 2 (16.7) | 1 (8.3) |
Preferred term . | All grades, n (%) . | Grade ≥3, n (%) . |
---|---|---|
Cough | 5 (41.7) | 0 |
Neutropenia | 5 (41.7) | 2 (16.7) |
Upper respiratory tract infection | 4 (33.3) | 0 |
Contusion | 3 (25) | 0 |
Dyspnea | 3 (25) | 1 (8.3) |
Fatigue | 3 (25) | 0 |
Peripheral swelling | 3 (25) | 1 (8.3) |
Petechiae | 3 (25) | 0 |
Abdominal distension | 2 (16.7) | 0 |
Arthralgia | 2 (16.7) | 0 |
Basal cell carcinoma | 2 (16.7) | 0 |
Chronic obstructive pulmonary disease | 2 (16.7) | 1 (8.3) |
Electrocardiogram QT prolonged | 2 (16.7) | 1 (8.3) |
Epistaxis | 2 (16.7) | 0 |
Gastroesophageal reflux disease | 2 (16.7) | 0 |
Nausea | 2 (16.7) | 0 |
Nephrolithiasis | 2 (16.7) | 1 (8.3) |
Edema peripheral | 2 (16.7) | 0 |
Oral herpes | 2 (16.7) | 0 |
Pruritus | 2 (16.7) | 0 |
Rhinitis allergic | 2 (16.7) | 0 |
Sinusitis | 2 (16.7) | 0 |
Squamous cell carcinoma of skin | 2 (16.7) | 0 |
Thrombocytopenia | 2 (16.7) | 1 (8.3) |
Urinary tract infection | 2 (16.7) | 1 (8.3) |